Harry Bartelink - Concepedia

Author

Harry Bartelink

Also Known As

Bartelink, Harry, E Van Cutsem, H BARTELINK, H Bartelink, H. BARTELINK, H. Bartelink, H. G. M. Bartelink, H. bartelink, Harry Bartelink, Harry G M M Bartelink

452

Publications

37.3K

Citations

H-Index

178

Concepts

All Affiliations

The Netherlands Cancer Institute European Organisation for Research and Treatment of Cancer Instituut Verbeeten Oncode Institute Centre Georges François Leclerc

About

Harry Bartelink is an author at The Netherlands Cancer Institute specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	36	62	4.4K
2	Engineering	12	12	2K
3	Arts	1	1	16
4	Business	1	1	16
5	Management	1	1	16

Harry Bartelink

203

Publications

34.2K

Citations

H-Index

Page 1

	Year	Citations
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer Marc J. van de Vijver, Yudong D. He, Laura van ‘t Veer, New England Journal of Medicine	2002	6.5K
Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. Harry Bartelink, F. Roelofsen, F. Eschwège, Journal of Clinical Oncology	1997	1.3K
Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer C. Schaake-Koning, Walter Van den Bogaert, Otilia Dalesio, New England Journal of Medicine	1992	1.3K
Impact of a Higher Radiation Dose on Local Control and Survival in Breast-Conserving Therapy of Early Breast Cancer: 10-Year Results of the Randomized Boost Versus No Boost EORTC 22881-10882 Trial Harry Bartelink, Jean-Claude Horiot, Philip Poortmans, Journal of Clinical Oncology	2007	1K
Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer Philip Poortmans, Sandra Collette, Carine Kirkove, New England Journal of Medicine	2015	1K
Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival Howard Y. Chang, Dimitry S.A. Nuyten, Julie B. Sneddon, Proceedings of the National Academy of Sciences Breast OncologyEngineeringPrognosisPathologyCancer Biology	2005	982
Recurrence Rates after Treatment of Breast Cancer with Standard Radiotherapy with or without Additional Radiation Harry Bartelink, Jean-Claude Horiot, Philip Poortmans, New England Journal of Medicine	2001	937
Long-Term Risk of Cardiovascular Disease in 10-Year Survivors of Breast Cancer Maartje J. Hooning, Akke Botma, Berthe M.P. Aleman, JNCI Journal of the National Cancer Institute	2007	859
Late cardiotoxicity after treatment for Hodgkin lymphoma Berthe M.P. Aleman, Alexandra W. van den Belt‐Dusebout, Marie L. De Bruin, Blood	2006	753
Long-Term Cause-Specific Mortality of Patients Treated for Hodgkin’s Disease Berthe M.P. Aleman, Alexandra W. van den Belt‐Dusebout, Willem J. Klokman, Journal of Clinical Oncology	2003	710

Page 1